background image

Paid Clinical Trials Hattiesburg

Discover 27 paid clinical trials in Hattiesburg, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

for
Colorectal Cancer
1 location in Hattiesburg
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06562543

Recruiting

A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity

for
Osteoarthritis, Knee, Obesity
1 location in Hattiesburg
Sponsor: University of Southern Mississippi

Sex: All

Age: 30 - 70+

Code: NCT05997862

Phase1, Phase2, Recruiting

Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

for
Chemotherapy-induced Nausea and Vomiting
1 location in Hattiesburg
Sponsor: Xiamen LP Pharmaceutical Co., Ltd

Sex: All

Age: 18+

Code: NCT05199818

Phase3, Recruiting

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

for
Myelodysplastic Syndromes
1 location in Hattiesburg
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05949684

Phase3, Recruiting

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
1 location in Hattiesburg
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05827016

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

for
Non-small Cell Lung Cancer
1 location in Hattiesburg
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06561386

Phase3, Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

for
Follicular Lymphoma
1 location in Hattiesburg
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06911502

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

for
Non-small Cell Lung Cancer (NSCLC)
1 location in Hattiesburg
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06170788

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

for
Non-small Cell Lung Cancer (NSCLC)
1 location in Hattiesburg
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06074588

Phase3, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
1 location in Hattiesburg
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting